Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(80.0%)
Early Phase 1
1(20.0%)
5Total
N/A(4)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06578273Early Phase 1Completed

NeuroGlove PD Study Clinical

Role: lead

NCT06050590Not ApplicableUnknown

NeuroGlove PTSD Study

Role: lead

NCT05961293Not ApplicableUnknown

NeuroGlove fMRI Study

Role: lead

NCT06573840Not ApplicableWithdrawn

A Functional MRI Study: Assessing Brain Function in Post Stoke Patients

Role: lead

NCT06065787Not ApplicableUnknown

NeuroGlove Anxiety and Depression Study

Role: lead

All 5 trials loaded